Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akihiro Kitadate

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Ejhaem|July 18, 2022
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsyKosei Matsue, Yoshiaki Abe, Kentaro Narita, et al.
International Journal of Hematology|April 10, 2019
Evaluation of the safety and efficacy of daratumumab outside of clinical trialsHiroki Kobayashi, Takafumi Tsushima, Toshiki Terao, et al.
Oncotarget|February 26, 2019
N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myelomaYoshiaki Abe, Tetsuya Kobayashi, Yoshiaki Usui, et al.
Cancer Medicine|April 21, 2020
Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myelomaHiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, et al.
Annals of Hematology|August 25, 2018
Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphomaYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2019
Pretreatment <sup>18</sup>F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myelomaYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Oncotarget|January 21, 2016
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphomaSho Ikeda, Akihiro Kitadate, Mitsugu Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 4, 2024
[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]Akihito Saito, Miho Nara, Takashi Fujishima, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Ejhaem|July 18, 2022
Bone marrow infiltration pattern in patients with intravascular large B-cell lymphoma diagnosed by random skin biopsyKosei Matsue, Yoshiaki Abe, Kentaro Narita, et al.
International Journal of Hematology|April 10, 2019
Evaluation of the safety and efficacy of daratumumab outside of clinical trialsHiroki Kobayashi, Takafumi Tsushima, Toshiki Terao, et al.
Oncotarget|February 26, 2019
N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myelomaYoshiaki Abe, Tetsuya Kobayashi, Yoshiaki Usui, et al.
Cancer Medicine|April 21, 2020
Association between serum erythropoietin levels and renal reversibility in patients with renal impairment from multiple myelomaHiroki Kobayashi, Toshiki Terao, Takafumi Tsushima, et al.
Annals of Hematology|August 25, 2018
Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphomaYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2019
Pretreatment <sup>18</sup>F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myelomaYoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, et al.
Cancer Science|July 21, 2021
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependenceAkihiro Kitadate, Toshiki Terao, Kentaro Narita, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 24, 2019
Low hexokinase-2 expression-associated false-negative <sup>18</sup>F-FDG PET/CT as a potential prognostic predictor in patients with multiple myelomaYoshiaki Abe, Sho Ikeda, Akihiro Kitadate, et al.
Oncotarget|January 21, 2016
Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphomaSho Ikeda, Akihiro Kitadate, Mitsugu Ito, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 4, 2024
[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]Akihito Saito, Miho Nara, Takashi Fujishima, et al.
Pageof 5